Is XRAY stock a Buy, Sell, or Hold?

Based on our analysis, XRAY is currently a HOLD with low confidence. 📊 HOLD: XRAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of XRAY stock?

Our analysis estimates the fair value range for XRAY to be between $11.59 and $13.81. The current price is $10.92.

What is the analyst price target for XRAY?

The average Wall Street analyst price target for XRAY is $13.59. This implies a potential upside of 23.2% from current levels.

XRAY Stock Analysis: Buy, Sell, or Hold?

XRAY - DENTSPLY SIRONA Inc.

DENTAL EQUIPMENT & SUPPLIES

$10.92

0.14 (1.30%) ▲

5d: -5.78%

30d: -14.15%

90d: +9.97%

HOLD

LOW Confidence

Protect Your XRAY Gains

Analysis Updated: Aug 21, 2026 12:00 AM ET

Earnings: Aug 06, 2026 0d

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Aug 7, 2026 at $12.12 · last confirmed Aug 17, 2026

Strength: 6.5/10

Get Alerted When XRAY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: XRAY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 1.4%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$13.24

Based on 2.7% avg growth

INTRINSIC VALUE TODAY

$8.22

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.6x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: XRAY is currently trading at $10.92, which is considered oversold relative to its 30-day fair value range of $11.59 to $13.81. The stock's valuation (Forward PE: 7.2) is in line with its historical norms (7.6). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This pessimistic expectation contrasts with the company's recent 15.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, XRAY is in a uptrend. The price is currently testing key support at $10.75. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: XRAY scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $13.59 (+23.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $11.59 - $13.81

Company Quality Score 57/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 90.5%

Protect Your Profits

Holding XRAY? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BULLISH: Strong technical setup (65/100)
BULLISH: High volume confirmation
BULLISH: Trading 23.2% below Wall St target ($13.59)
CAUTION: Bottoming setup, but lagging the sector by 15% over 20 days — wait for relative strength
CAUTION: 5-day price weakness (-5.8%) - monitor closely

Trading Range Analysis

30-Day Trading Range $11.59 - $13.81

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $10.75

Resistance Level $12.12

Current Trend Uptrend

Technical data as of Aug 21, 2026

Fundamental Context

Forward P/E (Next Year Est.) 7.23

Wall Street Target $13.59 (+23.2%)

Revenue Growth (YoY) -4.1%

Earnings Growth (YoY) 15.2%

Profit Margin -15.0%

Valuation Discount vs History -1.8% cheaper

PE vs Historical 7.2 vs 7.6 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -1.8% (market-implied from PE analysis)

1-Year Target $10.83 (-2%)

2-Year Target $10.64 (-4%)

3-Year Target $10.45 (-5%)

3-Yr Target (if PE normalizes) (PE: 7→8) $10.97 (-1%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.1, Growth: 1.4%) $31.87 (+189%)

Base: (SPY PE: 7.2, Growth: 1.4%) $11.49 (+4%)

Bear: (PE: 6.1, Growth: 1.4%) $9.76 (-12%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 7.2 to 7.6

Stabilization Target: $11.59 (+5.0%)

PE Expansion Potential: +5.0%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: August 23, 2026 1:29 AM ET
Data refreshes hourly during market hours. Next update: 2:29 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is XRAY showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS BUYING

Recent Transactions

Gregory T Lucier BUY 15000 shares 2026-03-09

James D Forbes BUY 5000 shares 2026-03-09

Gregory T Lucier BUY 22445 shares 2026-03-03

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for XRAY.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
ISRG Intuitive Surgical Inc	BUY 33 analysts	$478	46 HOLD
ALC Alcon AG	STRONG BUY 27 analysts	$86	37 SELL
WST West Pharmaceutical Serv…	STRONG BUY 13 analysts	$405	66 BUY
RGEN Repligen Corporation	STRONG BUY 19 analysts	$186	45 HOLD
RMD ResMed Inc	BUY 19 analysts	$247	41 HOLD

ISRG Intuitive Surgica…

46 HOLD

ALC Alcon AG

37 SELL

WST West Pharmaceutic…

66 BUY

RGEN Repligen Corporat…

45 HOLD

RMD ResMed Inc

41 HOLD

Advanced XRAY Option Strategies

Professional options setups generated by AI based on today's XRAY price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for XRAY

XRAY Technical Chart XRAY Price Prediction XRAY Earnings Date XRAY Investment Advisor XRAY Fair Price Analyzer XRAY Options Advisor XRAY Options Chain XRAY Options Analysis XRAY Competitors

Compare XRAY with Peers

XRAY vs HSIC
Which one to buy?

XRAY vs COO
Which one to buy?

XRAY vs CHRW
Which one to buy?

XRAY vs TFX
Which one to buy?

XRAY vs EXPD
Which one to buy?

WAT vs XRAY
Winner: Tie

LAMR vs XRAY
Winner: Tie

MMSI vs XRAY

XRAY vs KMTS
Winner: XRAY

Create New Comparison View All Competitors

Tradestie